Wenn-Chyau Lee received his BSc (Hons) degree in Biomedical Sciences from University of Malaya, Malaysia in year 2011, and graduated with his PhD in Medical Sciences from University of Malaya in year 2014. Subsequently, he joined Singapore Immunology Network (SIgN, A*STAR) as a research fellow in Laurent Renia’s Laboratory. He was appointed as SIgN fellow after receiving OF-YIRG grant awarded by the National Medical Research Council (NMRC) of Singapore in year 2018. He joined the newly formed A*STAR ID Labs as an investigator in year 2021. Subsequently, he joined the Department of Parasitology, Faculty of Medicine, Universiti Malaya as a senior lecturer. Currently, he is also an adjunct investigator in A*STAR ID Labs, Singapore. As a parasitologist, he has involved in studies encompassing a number of medically important parasites such as the malaria causative agent Plasmodium spp., Toxoplasma gondii that can cause birth defects, Brugia pahangi that can cause symptomatic zoonotic filariasis, as well as several medically important vectors. His main research interest revolves around the immuno-pathobiology of malaria. He has been investigating and deciphering the roles of rosetting (a phenomenon where a Plasmodium-infected red blood cell is stably adhered to uninfected red blood cells, forming a flower-like structure called ‘rosette’) in the pathogenesis of malaria. Besides, he is looking into the potential of applying biocontrol strategy to eliminate different vector borne diseases. He has worked as a research fieldworker in different places including the Thai-Burmese Border, China, peninsular Malaysia and Malaysian Borneo. As different laboratory settings are equipped differently, he enjoys adapting and improvising facilities available in the field sites to conduct experiments. Currently, he is also the facility coordinator of the insectary and arthropod containment level 2 (ACL2) research unit in the Faculty of Medicine, Universiti Malaya. To date, he has published (as first/ corresponding author) in a number of reputable journals such as Blood, EBioMedicine, eLife, Frontiers in Immunology, Frontiers in Microbiology, and Trends in Parasitology. Besides working as a reviewer for many scientific journals and grant evaluation committees, he is also an editorial board member of Frontiers in Microbiology.

Lip Yee Por is a Full Professor at the Faculty of Computer Science and Information Technology, Universiti Malaya, Malaysia. A Senior Member of IEEE, he is a recognized expert in security and machine learning. His research interests include AI, deep learning, support vector machines (SVM), IoT, authentication, computer vision, blockchain, cryptography, steganography, and watermarking. He has authored over 100 peer-reviewed publications in reputable international journals and has secured more than RM 7 million in competitive research funding as Principal Investigator. Prof. Por’s impactful contributions have earned him numerous national and international awards, and he is consistently recognized as one of the top-rated lecturers at FCSIT. In addition to his research and teaching excellence, he serves as Associate Editor for Frontiers in Public Health, Frontiers in Computer Science, and the Malaysian Journal of Computer Science, as well as Guest Editor for Applied Sciences. He is also an Editorial Board Member for CMC-Computers, Materials & Continua. He has held key leadership roles in national and international conferences as Program Chair, Technical Chair, and Local Chair, and serves as an external academic assessor for academic programs at TARUC, MMU, HELP, and APU. To date, he has delivered more than 20 keynote and invited speeches at national and international conferences.

Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes.